ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,035,694 | -28.8% | 4,572,977 | -0.0% | 0.02% | -27.6% |
Q2 2023 | $29,551,826 | -14.9% | 4,574,586 | -0.7% | 0.03% | -17.1% |
Q1 2023 | $34,745,526 | -16.4% | 4,608,160 | +12.4% | 0.04% | -20.5% |
Q4 2022 | $41,538,014 | +2.4% | 4,100,495 | -0.0% | 0.04% | -2.2% |
Q3 2022 | $40,564,000 | +46.8% | 4,101,471 | +58.1% | 0.04% | +55.2% |
Q2 2022 | $27,625,000 | +6.7% | 2,593,958 | -2.3% | 0.03% | +31.8% |
Q1 2022 | $25,884,000 | -31.2% | 2,654,714 | +0.9% | 0.02% | +10.0% |
Q4 2021 | $37,631,000 | -33.0% | 2,631,525 | -6.1% | 0.02% | -35.5% |
Q3 2021 | $56,160,000 | -3.2% | 2,802,411 | +6.3% | 0.03% | 0.0% |
Q2 2021 | $57,987,000 | -24.8% | 2,635,773 | +16.1% | 0.03% | -20.5% |
Q1 2021 | $77,116,000 | – | 2,270,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |